Protech
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • The recent passage of Bill HB-3740 will increases the size of the eligible patient population for Reliq’s services in the state of Texas
  • Beginning September 1, Texas Medicaid’s Telemonitoring (Remote Patient Monitoring) program will cover patients with a wide variety of conditions
  • Using Reliq’s iUGO Care platform, Reliq’s clients can currently leverage over 18 different billing codes to generate revenue streams for their practices
  • Reliq’s powerful iUGO Care platform allows complex patients to receive high-quality care at home
  • Reliq Health Technologies (RHT) opened trading at C$0.44 per share

Reliq Health Technologies (RHT) provided an update on the recent expansion of Texas Medicaid’s Telemonitoring program.

This expansion significantly increases the size of the eligible patient population for Reliq’s services in the state of Texas.

“Since its inception in 2014 to this point, Texas Medicaid’s Telemonitoring (Remote Patient Monitoring) program has only covered patients with two conditions – hypertension and diabetes,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies.

“With the recent passage of Bill HB-3740, effective September 1, 2021 the Telemonitoring program in Texas is expanding dramatically to include an additional nine eligible conditions: pregnancy, heart disease, cancer, chronic obstructive pulmonary disease, congestive heart failure, mental illness or serious emotional disturbance, asthma, myocardial infarction and stroke, more than doubling the size of the target patient population for Reliq in this state.

This significant change to the scope of Texas Medicaid’s Telemonitoring program is consistent with the overall trends in Medicare and Medicaid coverage for Remote Patient Monitoring (RPM) and other virtual care services for patients with chronic conditions.

Since the federal Medicare program first introduced its own billing code for RPM in 2018, the Centers for Medicare and Medicaid Services have consistently expanded the virtual care services covered and the total reimbursement amounts every year.

Using Reliq’s iUGO Care platform, Reliq’s clients can currently leverage over 18 different billing codes to provide high-quality health care to their patients remotely and generate new, high-profit revenue streams for their practices.

The chronic condition management market is large and rapidly growing, and Reliq’s industry-leading, powerful, flexible iUGO Care platform is uniquely able to support healthcare providers looking to offer new virtual care services to their patients.”

Reliq specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home.

Reliq Health Technologies Inc. (RHT) opened trading at C$0.44 per share.

More From The Market Herald

" Hemostemix (TSXV:HEM) announces non-brokered private placement

Hemostemix (HEM) has announced a non-brokered private placement of up to 15 million units.
WELL Health - Chairman & CEO Hamed Shahbazi

" WELL Health (TSX:WELL) closes $34.5M public offering

WELL Health Technologies Corp. (WELL) has completed a bought deal public offering for proceeds of $34.5 million.

" Simply Better Brands (TSXV:SBBC) enters the weight loss category

Simply Better Brands (SBBC) has launched its entry into the weight loss category with a PureKana Keto Gummy.

" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.